The sickle-cell disease (SCD) as the most frequent type of hemoglobinopathy is treated with analgesics, antibiotics, angiotensin converting enzyme (ACE) inhibitors and hydroxyurea [1]. This evidence concerns the gene ACE and hemoglobinopathy.